Anti-India patent law US congressional letter

170 Members of Congress have sent a letter to US President Obama citing concerns over growing trade imbalance between US and India accruing it to the policy changes and court decision favoring domestic pharma industry over MNCs.

In the letter, Congress members highlighted that  actions by Indian Government like issuance of Compulsory License for a pharmaceutical drugs greatly concern them as this is having negative impact on innovation and IP which are the driving forces behind US economic growth.

Read the letter here

 

This entry was posted in Compulsory Licensing, Innovation, IP Rights, Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s